VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 60 filers reported holding VIRACTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $300,114 | -26.2% | 288,571 | 0.0% | 0.12% | -37.7% |
| Q2 2023 | $406,885 | -11.3% | 288,571 | 0.0% | 0.20% | -10.0% |
| Q1 2023 | $458,828 | +8.9% | 288,571 | 0.0% | 0.22% | -20.5% |
| Q4 2022 | $421,314 | -65.8% | 288,571 | 0.0% | 0.28% | -66.0% |
| Q3 2022 | $1,232,000 | +10.0% | 288,571 | 0.0% | 0.82% | +2.4% |
| Q2 2022 | $1,120,000 | -18.5% | 288,571 | 0.0% | 0.80% | +7.8% |
| Q1 2022 | $1,374,000 | +30.5% | 288,571 | 0.0% | 0.74% | +99.7% |
| Q4 2021 | $1,053,000 | -54.5% | 288,571 | 0.0% | 0.37% | -19.5% |
| Q3 2021 | $2,314,000 | -29.3% | 288,571 | 0.0% | 0.46% | -12.0% |
| Q2 2021 | $3,272,000 | – | 288,571 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 689,709 | $717,297 | 0.22% |
| Aisling Capital Management LP | 288,571 | $300,114 | 0.12% |
| BVF INC/IL | 3,614,662 | $3,759,248 | 0.10% |
| TRUST CO OF TOLEDO NA /OH/ | 33,213 | $34,542 | 0.01% |
| MAI Capital Management | 397,670 | $413,577 | 0.01% |
| Laurion Capital Management LP | 698,000 | $725,920 | 0.00% |
| RP Management, LLC | 3,700 | $3,848 | 0.00% |
| UNITED BANK | 20,000 | $20,800 | 0.00% |
| BOURGEON CAPITAL MANAGEMENT LLC | 7,500 | $7,800 | 0.00% |
| XTX Topco Ltd | 12,084 | $12,567 | 0.00% |